Shared APC Neoantigen Data for Cancer Vaccine Proof-of-Concept

A 2026 study by Alfred J. Simmons presents bioinformatics and in vivo data supporting a cancer vaccine concept. The research identifies shared neoantigen epitopes from the APC gene in colorectal cancer patients and tests a self-amplifying RNA vaccine delivered via virus-like nanoparticles. The dataset includes in vitro T-cell activation results and in vivo immune response data from mouse serum samples.

Use Cases

• Identifying shared neoantigen epitopes based on mutation analysis of the APC gene mutational cluster region.
• Designing cancer vaccine constructs based on mutated APC sequences inserted into a wild-type APC backbone.
• Evaluating T-cell mediated immune responses based on in vitro activation assays against neoantigen peptide fragments.
• Assessing in vivo vaccine immunogenicity based on neoantigen-specific IgG titers measured in mouse serum.

Strengths

• Focuses on a high-impact target, as over 80% of colorectal cancer cases are linked to APC gene mutations.
• Includes both in vitro and in vivo experimental validation, providing a multi-layered proof-of-concept.
• Released under a permissive CC-BY-4.0 license, facilitating reuse and sharing.

Limitations

• The dataset is a single PDF file (194.9 KB), suggesting limited scope and likely containing summarized results rather than raw data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for large-scale computational analysis.

Provenance

Source

figshare

Collection Method

Bioinformatics analysis and experimental validation in a research study.

Freshness

Last updated 2026-06-04 05:19:33; freshness should be verified.